Exploring adjuvant endocrine therapy use with letrozole in postmenopausal women with hormone receptor-positive breast cancer

Long-term influence of oestrogen plus progestin vs oestrogen alone on breast cancer incidence in post-menopausal women

Breast cancer prevention in high-risk post-menopausal women

Preventative effects of anastrozole in post-menopausal women who are at high-risk for developing breast cancer

Breast cancer incidence in post-menopausal women: Long-term influence of oestrogen plus progestin versus oestrogen alone

Addition of S-1 to post-operative endocrine therapy for patients with hormone receptor-positive HER2-negative breast cancer

Laser therapy for vulvo-vaginal atrophy / genito-urinary syndrome of menopause in breast cancer survivors

PROfound: PARP inhibitor olaparib compared with new hormonal agents in advanced castration resistant prostate cancer

Highlights from ESMO 2019

Prostate cancer updates: Advances in precision medicine and PARP inhibitors

Breast cancer highlights from ESMO 2019

Melanoma highlights from ESMO 2019